Altered cytokine expression in mesenteric lymph nodes in a rat strain (Matsumoto Eosinophilic Shinshu) that spontaneously develops hypereosinophilia

Immunology

Volumn 116, Issue 3, 2005, Pages 373-380

  Muto, Shin Ichi ^a   Monnai, Makoto ^b   Okuhara, Yuji ^a   Murakami, Makoto ^a   Kuroda, Junji ^a   Ono, Tamao ^b   Matsumoto, Kiyoshi ^b  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

Author keywords

Autoantibodies; Cytokine; Eosinophilia; Interleukin 5; Rat

Indexed keywords

CD3 ANTIGEN; CELL NUCLEUS ANTIGEN; EOTAXIN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; HYPEREOSINOPHILIA; HYPERGAMMAGLOBULINEMIA; LEUKOCYTOSIS; LYMPHOCYTE; MALE; MESENTERY LYMPH NODE; NEUTROPHILIA; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RAT STRAIN; REVERSE TRANSCRIPTION; TH1 CELL; TH2 CELL; THYMUS;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; CYTOKINES; DISEASE MODELS, ANIMAL; HYPEREOSINOPHILIC SYNDROME; IMMUNOGLOBULIN M; INTERLEUKIN-5; LYMPH NODES; MALE; MESENTERY; RATS; RATS, MUTANT STRAINS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 27444440163     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2005.02237.x     Document Type: Article

References (34)

1. Brito-Babapulle F. The eosinophilias, including idiopathic hypereosinophilic syndrome. Br J Haematol 2003; 121:203-23.
2. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338:1592-600.
3. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83:2759-79.
4. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996; 9:532-62.
5. Luster AD. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-45.
6. Matsumoto K, Matsushita N, Tomozawa H, Tagawa Y. Hematological characteristics of rats spontaneously developing eosinophilia. Exp Anim 2000; 49:211-5.
7. Muto S, Hayashi M, Matsushita N, Momose Y, Shibata N, Umemura T, Matsumoto K. Systemic and eosinophilic lesions in rats with spontaneous eosinophilia (mes rats). Vet Pathol 2001; 38:346-50.
8. Muto S, Kawakubo M, Matsushita N, Maeda N, Momose Y, Matsumoto K. Haematological data for Matsumoto Eosinophilic Shinshu rats as determined by an automated haematology analyser. Lab Anim 2005; 39:122-9.
9. Schielen P, Schoo W, Tekstra J, Oostermeijer HH, Seinen W, Bloksma N. Autoimmune effects of hexachlorobenzene in the rat. Toxicol Appl Pharmacol 1993; 122:233-43.
10. Bullock ED, Johnson EM Jr. Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion. J Biol Chem 1996; 271:27500-8.
11. Haddad el-B, Underwood SL, Dabrowski D et al. Critical role for T cells in Sephadex-induced airway inflammation: pharmacological and immunological characterization and molecular biomarker identification. J Immunol 2002; 168:3004-16.
12. Kusama Y, Takamoto M, Kasahara T, Takatsu K, Nariuchi H, Sugane K. Mechanisms of eosinophilia in BALB/c-nu/+ and congenitally athymic BALB/c-nu/nu mice infected with Toxocara canis. Immunology 1995; 84:461-8.
13. Grouls V, Helpap B. Selective staining of eosinophils and their immature precursors in tissue sections and autoradiographs with Congo red. Stain Technol 1981; 56:323-5.
14. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992; 79:3101-9.
15. Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988; 167:332-44.
16. Moon BG, Takaki S, Miyake K, Takatsu K. The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production. J Immunol 2004; 172:6020-9.
17. Horikawa K, Kaku H, Nakajima H et al. Essential role of Stat5 for IL-5-dependent IgH switch recombination in mouse B cells. J Immunol 2001; 167:5018-26.
18. Tominaga A, Takaki S, Koyama N et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med 1991; 173:429-37.
19. Smith JH, Von Lichtenberg F. The Hoeppli phenomenon in schistosomiasis. II. Histochemistry. Am J Pathol 1967; 50:993-1007.
20. Williams AO, Von Lichtenberg F, Smith JH, Martinson FD. Ultrastructure of phycomycosis due to Entomophthora, Basidiobolus, and associated 'Splendore-Hoeppli' phenomenon. Arch Pathol 1969; 87:459-68.
21. Lebman DA, Coffman RL. Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures. J Exp Med 1988; 168:853-62.
22. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236:944-7.
23. Abadie A, Prouvost-Danon A. Specific and total IgE responses to antigenic stimuli in Brown-Norway, Lewis and Sprague-Dawley rats. Immunology 1980; 39:561-9.
24. Robinson P, Atmar RL, Lewis DE, White AC Jr. Granuloma cytokines in murine cysticercosis. Infect Immun 1997; 65:2925-31.
25. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182:1169-74.
26. Mould AW, Matthaei KI, Young IG, Foster PS. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997; 99:1064-71.
27. Mowen KA, Glimcher LH. Signaling pathways in Th2 development. Immunol Rev 2004; 202:203-22.
28. Liu C, Lu J, Tan J, Li L, Huang B. Human interleukin-5 expression is synergistically regulated by histone acetyltransferase CBP/p300 and transcription factors C/EBP, NF-AT and AP-1. Cytokine 2004; 27:93-100.
29. Rothkotter HJ, Pabst R, Bailey M. Lymphocyte migration in the intestinal mucosa: entry, transit and emigration of lymphoid cells and the influence of antigen. Vet Immunol Immunopathol 1999; 72:157-65.
30. Brugnoni D, Airo P, Rossi G et al. A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 1996; 87:1416-22.
31. Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994; 330:535-8.
32. Kitano K, Ichikawa N, Mahbub B et al. Eosinophilia associated with proliferation of CD(3+) 4-(8-) αβ+ T cells with chromosome 16 anomalies. Br J Haematol 1996; 92:315-7.
33. Simon HU, Yousefi S, Dommann-Scherrer CC, Zimmermann DR, Bauer S, Barandun J, Blaser K. Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996; 183:1071-82.
34. Guy-Grand D, Azogui O, Celli S, Darche S, Nussenzweig MC, Kourilsky P, Vassalli P. Extrathymic T cell lymphopoiesis, ontogeny and contribution to gut intraepithelial lymphocytes in athymic and euthymic mice. J Exp Med 2003; 197:333-41.